- Home
- RXT vs ORIC Comparison
RXT vs ORIC Comparison
Compare RXT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- ORIC
- Stock Information
- Founded
- RXT 1998
- ORIC 2014
- Country
- RXT United States
- ORIC United States
- Employees
- RXT N/A
- ORIC N/A
- Industry
- RXT EDP Services
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- RXT Technology
- ORIC Health Care
- Exchange
- RXT Nasdaq
- ORIC Nasdaq
- Market Cap
- RXT 351.3M
- ORIC 362.9M
- IPO Year
- RXT 2020
- ORIC 2020
- Fundamental
- Price
- RXT $1.33
- ORIC $11.44
- Analyst Decision
- RXT Hold
- ORIC Strong Buy
- Analyst Count
- RXT 4
- ORIC 9
- Target Price
- RXT $1.63
- ORIC $18.29
- AVG Volume (30 Days)
- RXT 1.1M
- ORIC 708.1K
- Earning Date
- RXT 08-07-2025
- ORIC 08-11-2025
- Dividend Yield
- RXT N/A
- ORIC N/A
- EPS Growth
- RXT N/A
- ORIC N/A
- EPS
- RXT N/A
- ORIC N/A
- Revenue
- RXT $2,711,700,000.00
- ORIC N/A
- Revenue This Year
- RXT N/A
- ORIC N/A
- Revenue Next Year
- RXT $1.48
- ORIC N/A
- P/E Ratio
- RXT N/A
- ORIC N/A
- Revenue Growth
- RXT N/A
- ORIC N/A
- 52 Week Low
- RXT $1.00
- ORIC $3.90
- 52 Week High
- RXT $3.41
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- RXT 46.34
- ORIC 63.57
- Support Level
- RXT $1.18
- ORIC $10.88
- Resistance Level
- RXT $1.51
- ORIC $12.00
- Average True Range (ATR)
- RXT 0.13
- ORIC 0.56
- MACD
- RXT -0.01
- ORIC -0.05
- Stochastic Oscillator
- RXT 34.52
- ORIC 64.56
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.